PTYLTD
    • Free Reports
    • Videos
  • Pricing
  • About us
  • Contact us
  • Login | Sign up
PTYLTD

Free Reports

Videos

Pricing

About us

Contact us

  • Home
  • Insights into ASX Stocks
  • By Topic
  • Breakouts

Breakouts

Bapcor (ASX: BAP)

Bapcor (ASX: BAP)'s Double Signal: Turnaround Gains Traction Meets a Multi-Month Breakout

Sep 3, 2026
Proactive Equities Team

Bapcor’s FY26 turnaround shows improving sales momentum, lower debt, tighter pricing controls and stronger stock availability, though weak earnings, execution risks and cost pressures mean the recovery still needs further proof.

X2M Connect (ASX: X2M)

X2M Connect (ASX: X2M): Big AI Deal, Bigger Growth Test

Sep 1, 2026
Proactive Equities Team

X2M Connect is expanding beyond smart metering into AI-enabled data centres, energy management and infrastructure services. A binding A$250 million-plus AI data centre agreement and new Seoul contracts boost growth potential, but execution, approvals, funding and profitability remain key risks.

Golden Deeps (ASX: GED)

Golden Deeps (ASX: GED):10-Month Descending Channel Ends as High-Grade Graceland Results Surge

Aug 27, 2026
Proactive Equities Team

Golden Deeps is advancing deeper drilling at Graceland after encouraging copper, silver and zinc results. Fresh assays and new targets have strengthened interest in the Namibian exploration program, while upcoming drilling will test the discovery’s potential scale.

AVITA Medical INC. (ASX: AVH)

AVITA Medical INC. (ASX: AVH): Technical Rally Driven by Solid Fundamentals

Aug 22, 2026
Proactive Equities Team

AVITA Medical is strengthening its commercial position as revenue growth improves, cash burn reduces, and its regenerative medicine portfolio expands. The company’s progress in product adoption and operational efficiency keeps it positioned as a speculative healthcare growth story.

Felix Gold (ASX: FXG)

Felix Gold (ASX: FXG) Surges Past Resistance on High Volume as US Antimony Extraction Momentum Accelerates

Aug 19, 2026
Proactive Equities Team

Felix Gold is advancing Alaskan antimony and gold assets, with potential US$18 million DOE pilot-processing funding driving investor interest. The non-dilutive funding could support domestic antimony supply, though project execution, permitting and financing risks remain.

BlinkLab (ASX: BB1)

BlinkLab (ASX: BB1) Gains Momentum: AI Screening Platform Meets a High-Volume BB1 Breakout

Aug 19, 2026
Proactive Equities Team

BlinkLab (ASX: BB1) is advancing its autism and ADHD assessment technology through clinical studies, FDA validation work, and research partnerships. Recent technical strength reflects growing investor interest, though regulatory and commercial risks remain.

Proactive Equities

At Proactive Equities, we combine deep market expertise with rigorous analysis to deliver stock recommendations you can trust. Our team of seasoned analysts continuously monitor global markets, economic trends, and company fundamentals to identify high-potential investment and trade opportunities.

Company

Home
Pricing
Contact Us
About Us

Resources

ASX Insights
Investing Basics
Videos

Links

Privacy Policy
Terms and Conditions
Product Disclosure Statement

Proactive Equities Pty Ltd (ACN: 687 232 471) is a Corporate Authorised Representative (AFSR No. 001318293) of Australia National Investment Group Pty Ltd (ABN: 40 636 343 630), which holds an Australian Financial Services Licence (AFSL no. 522028). The information on this website is general information only and does not constitute personal financial advice. We have not taken the individual circumstances, financial objectives or needs of any investor into account when preparing this information. Investors should consider their circumstances and the relevant PDS for any investment and obtain professional financial and tax advice before making any investment decision. The information on this website is not a recommendation to make any investment or to adopt any particular investment strategy. You should make your own professional assessment of the suitability of this information, relying on your own inquiries. Investments in securities are subject to investment risk. Investment value may go down as wellas up, and investors may not get back the full amount originally invested. Risks include: the investment objective may not be achieved, share market and other market risk, liquidity risk, and currency risk with international investments. Any past performance shown is not an indication of future performance. Commission and other costs charged by executing broker are not considered when calculating past performance. To the extent permitted by law Proactive Equities Pty Ltd accepts no liability for any errors or omissions in, or loss from reliance on the information in this website.

123456
Page 1 of 6